Differences

This shows you the differences between two versions of the page.

--- gillian_leng [2022/06/15 18:12]
liam
+++ gillian_leng [2022/06/16 01:42] (current)
liam
@@ Line 41: / Line 41: @@
 ==== International Society for Pharmacoeconomics and Outcomes Research (2018) ====
+Leng participated as a speaker at the [[International Society for Pharmacoeconomics and Outcomes Research|ISPOR Summit 2018]].((//Gillian Leng, CBE.// (2022). ISPOR | International Society for Pharmacoeconomics and Outcomes Research. https://archive.ph/V8kem))
 ==== Cochrane ====
@@ Line 48: / Line 49: @@
 Leng is a trustee of the [[Guidelines International Network]].
+==== European Society of Cardiology (2019) ====
+Leng delivered a presentation for the [[European Society of Cardiology]] at Digital Health 2019.((//A NICE perspective on real world evidence. Session at Digital Health 2019.// ESC 365. Retrieved June 15, 2022, from https://archive.ph/NjorQ)) The ESC 365 platform is sponsored by [[pharmaceutical_companies:Novo Nordisk]].
+==== GIANT Health (2020) ====
+Leng was scheduled as a speaker at the 2020 [[GIANT Health]] conference.((//Gillian Leng.// GIANT Health. Retrieved June 15, 2022, from https://archive.ph/3GT0J))
+==== Westminster Health Forum (2020) ====
+Leng was a speaker at a 2020 seminar called //The future for NICE in health and social care//,
+hosted by the [[Westminster Health Forum]].((//The future for NICE in health and social care.// (2022). Westminster Health Forum. https://archive.ph/70o8O))
 ==== Global Commission on Evidence to Address Societal Challenges ====